SCHEMBL9921932

SCHEMBL9921932

O=Cc1ccc(C(=O)OCC2CCCCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 4/20 0.47
PARP15 Q460N3 3/20 0.46
PARP10 Q53GL7 3/20 0.46
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
PARP2 Q9UGN5 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
JMJD6 Q6NYC1 1/20 0.43
LMNA P02545 1/20 0.41
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21309791 0.97 ALDH1A1 (0.50) MEN1KMT2AALDH1A1PARP15PARP10
SCHEMBL19218155 0.92 ALDH1A1 (0.51) MEN1KMT2AALDH1A1PARP15PARP10
SCHEMBL21309642 0.92 ALDH1A1 (0.51) MEN1KMT2AALDH1A1PARP15PARP10
SCHEMBL3468807 0.89 PARP15 (0.54) MEN1KMT2APARP15PARP10PARP2
SCHEMBL13270486 0.87 ALDH1A1 (0.46) MEN1KMT2AALDH1A1PARP15PARP10
SCHEMBL13261805 0.87 ALDH1A1 (0.46) MEN1KMT2AALDH1A1PARP15PARP10
SCHEMBL13267949 0.85 ALDH1A1 (0.49) MEN1KMT2AALDH1A1DRD2DRD4
SCHEMBL19214417 0.83 ALDH1A1 (0.51) KMT2AALDH1A1PARP15PARP10PARP2
SCHEMBL9764680 0.83 KMT2A (0.58) MEN1KMT2AALDH1A1PARP15PARP10
SCHEMBL2296496 0.83 DRD2 (0.49) MEN1KMT2APARP15PARP10DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230039846-A1 COMPOUNDS AND METHODS OF USE FERRO THERAPEUTICS INC (US) 2023-02-09 US disclosed
US-20190263802-A1 COMPOUNDS AND METHOD OF USE MOLECULAR SKIN THERAPEUTICS, INC. 2019-08-29 US disclosed
US-20120149830-A1 POLYESTER FILM AND METHOD OF FABRICATING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039846-A1 COMPOUNDS AND METHODS OF USE AIFM2, GPX4, GPX1 MEN1 1772/4885KMT2A 2510/4885ALDH1A1 1254/4885
US-20190263802-A1 COMPOUNDS AND METHOD OF USE AIFM2, GPX4, GPX1 MEN1 1681/4885KMT2A 2475/4885ALDH1A1 1190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.